Analysts Issue Forecasts for AGIO Q4 Earnings
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Investment analysts at HC Wainwright issued their Q4 2025 earnings estimates for Agios Pharmaceuticals in a research note issued on Monday, February 24th. HC Wainwright analyst E. Bodnar anticipates that the biopharmaceutical company will post earnings per share of ($1.42) for the quarter. HC Wainwright has a […]
